Tibet-medicine effects on β-amyloid pathology in a transgenic mouse model of Alzheimer's disease

Chinese Pharmacological Bulletin

Volumn 25, Issue 6, 2009, Pages

  Zhu, Ai Qin ^a   Chu, Yi De ^a   Li, Qiao Xin ^b   Masters, Colin L ^b  

^a BEIJING HOSPITAL   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; BACE 1; Open field activity and Y maze tests; Ratanasampil; Tg2576 mice; Tibet medicine; amyloid pathology

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CHINESE DRUG; RATANASAMPIL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OPEN FIELD TEST; TIBETAN MEDICINE; WESTERN BLOTTING;

EID: 68849124159     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Masters C L, Multhaup G, Simms G, et al. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels[J]. EMBO J,1985,4:2757-63.
2. Deshpande A, Mina E, Glabe C, et al. Different conformations of amyloid-beta induce neurotoxicity by distinct mechanisms in human cortical neurons[J]. Neuroscience,2006,26(22):6011-8.
3. Ida N, Hartmann T, Pantel J, et al. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay[J]. J Biol Chem,1996,271(37):22908-14.
4. Cole S L, Vassar R. The Alzheimer's disease β-secretase enzyme, BACE1[J]. Mol Neurodegener,2007,2:22.
5. Conrad C, Galea L A, Kuroda Y, et al. Chronic stress impairs rat spatial memory on the Y-maze and this effect is blocked by tianeptine pretreatment[J]. Behav Neurosci,1996,110:1321-34.
6. Weijers H G, Weyers P. Locomotor activity and defecation of rats o bserved alone and in pairs in repeated open-field sessions[J]. Percept Mot Skills,1998,86(3):1179-84.
7. Torreilles F, Touchon J. Pathogenic theories and intrathecal analysis of the sporadic from of Alzheimer's disease[J]. Progr Neurobiol,2002,66(3):191-203.
8. Bruni A C. Cloning of a gene bearing missense mutations in early onsetfamilial Alzheimer's disease: a Calabrian study[J]. Funct Neurol,1998,13(3):257-61.
9. [ 9 ] Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice[J]. Science,1996,274:99-102.
10. Barten D M, Albright C F. Therapeutic strategies for Alzheimer's disease[J]. Mol Neurobiol,2008,37(2-3):171-86.
11. Deshpande A, Mina E, Glabe C, et al. Different conformations of amyloid-beta induce neurotoxicity by distinct mechanisms in human cortical neurons[J]. Neuroscience,2006,26(22):6011-8.
12. Venugopal C, Demos C M, Rao K S, et al. Beta-secretase: structure, function, and evolution[J]. CNS Neurol Disord Drug Targets,2008,7(3):278-94.
13. Ghosh A K, Gemma S, Tang J. beta-Secretase as a therapeutic target for Alzheimer's disease[J]. Neurotherapeutics,2008,5(3):399-408.
14. An E J, Suo Y R. Progress in modern pharmacology on Tibet medicine Ratanasampil (RNSP)[J]. J Med Pharm Chin Minor,2004,4(2):33-5.